AMGN vs DSS · P/E 24, rev $36.75B vs rev $19.1M
Amgen Inc (AMGN) versus DSS Inc (DSS) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
DSS Inc (DSS) is a packaging & containers company listed on US.
Latest reported AMGN revenue for 2025-12-31 was $36.75B. Net income was $7.71B. Revenue was up 10.0% from 2024-12-31 to 2025-12-31. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported DSS revenue for 2024-12-31 was $19.1M. Net income was -$53.7M. Revenue was down 26.4% from 2023-12-31 to 2024-12-31. DSS currently screens at market cap $8.3M.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. DSS currently screens at market cap $8.3M.
Not investment advice. Open the AMGN and DSS stock pages for the full models.
Not investment advice.